Alleviare India Logo

ENTYVIO (VEDOLIZUMAB) 300MG INJECTION

Entyvio (vedolizumab) reduces the effects of a substance in the body that can cause inflammation. If you have question, please e-mail Allevaire Indian Team or call Allevaire Network on +91-9818274099 (Mr. Kamal Kaushal) for further details.

Entyvio is used in adults with moderate to severe ulcerative colitis (UC), or moderate to severe Crohn’s disease.

ENTYVIO (vedolizumab), an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion.

ENTYVIO (vedolizumab) Injection suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

ALLEVIARE LIFE SCIENCES connects buyer with the supplier who can ship ENTYVIO (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. ENTYVIO is manufactured by Takeda Pharmaceutical Company Limited

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for ENTYVIO (vedolizumab) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

ENTYVIO vedolizumab is indicated for:

the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha TNFa antagonist.

Treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFa) antagonist.

Medicine Name: ENTYVIO
Generic Name: vedolizumab
Approval Date: May 20, 2014
Available as (Form & Strength): 300 mg Injection for Intravenous use
Company Name: Takeda Pharmaceutical Company Limited

Please contact +91 9818274099 for ENTYVIO (vedolizumab) 300mg price in India.

We take guarantee of quality and delivery anywhere in the world as per the buyer’ s requirements.

entyvio 300 mg

ENTYVIO (vedolizumab) is available.

Get In Touch

    ENTYVIO (vedolizumab) Injection suppliers in India

    ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ENTYVIO (vedolizumab) Injection on prescription and Import License in Patient’s Name only.

    For foreign countries patients, ENTYVIO (vedolizumab) Injection can be made available in Send your inquiry to find ENTYVIO (vedolizumab) Injection in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for ENTYVIO (vedolizumab) Injection

    For ENTYVIO (vedolizumab) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details